CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection.
Saved in:
| Title: | CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection. |
|---|---|
| Authors: | Zheng J; Department of Microbiology and Immunology and.; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA., Dhakal H; Department of Microbiology and Immunology and., Qing E; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA., Shrestha R; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and., Geller AE; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and., Morrissey SM; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and., Saxena D; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA., Hu X; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and., Li H; Functional Immunomics Core, Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA., Li H; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and., Wilhelmsen K; BIOAGE Labs, Richmond, California, USA., Wendt LH; Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA., Klumpp K; BIOAGE Labs, Richmond, California, USA., Hume PS; Department of Medicine, Division of Pulmonary and Critical Care, National Jewish Health, Denver, Colorado, USA.; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA., Janssen WJ; Department of Medicine, Division of Pulmonary and Critical Care, National Jewish Health, Denver, Colorado, USA.; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA., Brody R; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Palmer KE; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.; Department of Pharmacology and Toxicology and., Uriarte SM; Department of Oral Immunology and Infectious Diseases, University of Louisville, Louisville, Kentucky, USA., Ten Eyck P; Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA., Meyerholz DK; Department of Pathology, University of Iowa, Iowa City, Iowa, USA., Merchant ML; Department of Medicine, Division of Nephrology and Hypertension and., McLeish K; Department of Medicine, Division of Nephrology and Hypertension and., Gallagher T; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA., Huang J; Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, Kentucky, USA., Yan J; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and., Perlman S; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2025 Jan 07; Vol. 135 (4). Date of Electronic Publication: 2025 Jan 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39773555 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zheng+J%22">Zheng J</searchLink>; Department of Microbiology and Immunology and.; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Dhakal+H%22">Dhakal H</searchLink>; Department of Microbiology and Immunology and.<br /><searchLink fieldCode="AU" term="%22Qing+E%22">Qing E</searchLink>; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Shrestha+R%22">Shrestha R</searchLink>; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and.<br /><searchLink fieldCode="AU" term="%22Geller+AE%22">Geller AE</searchLink>; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and.<br /><searchLink fieldCode="AU" term="%22Morrissey+SM%22">Morrissey SM</searchLink>; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and.<br /><searchLink fieldCode="AU" term="%22Saxena+D%22">Saxena D</searchLink>; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Hu+X%22">Hu X</searchLink>; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Functional Immunomics Core, Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and.<br /><searchLink fieldCode="AU" term="%22Wilhelmsen+K%22">Wilhelmsen K</searchLink>; BIOAGE Labs, Richmond, California, USA.<br /><searchLink fieldCode="AU" term="%22Wendt+LH%22">Wendt LH</searchLink>; Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Klumpp+K%22">Klumpp K</searchLink>; BIOAGE Labs, Richmond, California, USA.<br /><searchLink fieldCode="AU" term="%22Hume+PS%22">Hume PS</searchLink>; Department of Medicine, Division of Pulmonary and Critical Care, National Jewish Health, Denver, Colorado, USA.; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Janssen+WJ%22">Janssen WJ</searchLink>; Department of Medicine, Division of Pulmonary and Critical Care, National Jewish Health, Denver, Colorado, USA.; Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Brody+R%22">Brody R</searchLink>; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Palmer+KE%22">Palmer KE</searchLink>; Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, USA.; Department of Pharmacology and Toxicology and.<br /><searchLink fieldCode="AU" term="%22Uriarte+SM%22">Uriarte SM</searchLink>; Department of Oral Immunology and Infectious Diseases, University of Louisville, Louisville, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Ten+Eyck+P%22">Ten Eyck P</searchLink>; Institute for Clinical and Translational Science, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Meyerholz+DK%22">Meyerholz DK</searchLink>; Department of Pathology, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Merchant+ML%22">Merchant ML</searchLink>; Department of Medicine, Division of Nephrology and Hypertension and.<br /><searchLink fieldCode="AU" term="%22McLeish+K%22">McLeish K</searchLink>; Department of Medicine, Division of Nephrology and Hypertension and.<br /><searchLink fieldCode="AU" term="%22Gallagher+T%22">Gallagher T</searchLink>; Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Huang+J%22">Huang J</searchLink>; Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Yan+J%22">Yan J</searchLink>; Department of Microbiology and Immunology and.; Division of Immunotherapy, the Hiram C. Polk, Jr., MD, Department of Surgery, Immuno-Oncology Program, Brown Cancer Center and.<br /><searchLink fieldCode="AU" term="%22Perlman+S%22">Perlman S</searchLink>; Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2025 Jan 07; Vol. 135 (4). <i>Date of Electronic Publication: </i>2025 Jan 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39773555 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI188222 Languages: – Code: eng Text: English Titles: – TitleFull: CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zheng J – PersonEntity: Name: NameFull: Dhakal H – PersonEntity: Name: NameFull: Qing E – PersonEntity: Name: NameFull: Shrestha R – PersonEntity: Name: NameFull: Geller AE – PersonEntity: Name: NameFull: Morrissey SM – PersonEntity: Name: NameFull: Saxena D – PersonEntity: Name: NameFull: Hu X – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: Wilhelmsen K – PersonEntity: Name: NameFull: Wendt LH – PersonEntity: Name: NameFull: Klumpp K – PersonEntity: Name: NameFull: Hume PS – PersonEntity: Name: NameFull: Janssen WJ – PersonEntity: Name: NameFull: Brody R – PersonEntity: Name: NameFull: Palmer KE – PersonEntity: Name: NameFull: Uriarte SM – PersonEntity: Name: NameFull: Ten Eyck P – PersonEntity: Name: NameFull: Meyerholz DK – PersonEntity: Name: NameFull: Merchant ML – PersonEntity: Name: NameFull: McLeish K – PersonEntity: Name: NameFull: Gallagher T – PersonEntity: Name: NameFull: Huang J – PersonEntity: Name: NameFull: Yan J – PersonEntity: Name: NameFull: Perlman S IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 01 Text: 2025 Jan 07 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 135 – Type: issue Value: 4 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |